Desi Covid-19 vaccine Covaxin, which has been plagued by vaccine hesitancy after it was given EUA approval even as Phase III efficacy trials were underway, and Atmanirbhar Bharat got a major booster shot after Prime Minister Narendra Modi took the first jab of the indigenous vaccine on Monday morning.
Bharat Biotech, which has developed the whole virion, inactivated virus vaccine from scratch in India along with the Indian Council Medical Research-National Institute of Virology, Pune, said the personal example set by the PM will help reduce vaccine hesitancy and give a huge boost to the immunisation campaign against the pandemic.
“This has set a powerful example for all Indians to follow, which will go a long way in reducing vaccine hesitancy and building confidence in immunisation against the ongoing pandemic. We express our sincere gratitude to the Hon’ble Prime Minister for reposing his trust in the indigenously developed COVID-19 vaccine, COVAXIN. We urge all fellow citizens to not hesitate from taking part in the Covid-19 immunization program so that the country can bring an end to this public health crisis,” Bharat Biotech chairman & managing director Dr Krishna Ella said in a statement.
Earlier in the day, Bharat Biotech also tweeted its appreciation for the PM taking the desi vaccine. “Inspired and humbled by Hon’ble PM’s remarkable commitment to build an Atmanirbhar Bharat. Yes, we all shall fight #COVID-19 together and emerge victorious,” the company tweeted.
Source; Times of India